Web Analytics
Cổ phiếu GRFS (NASDAQ) | GRIFOLS SA ADR – Phân tích Deepscope
MARKET

Select Market Data Region

GRFS — GRIFOLS SA ADR (Healthcare >> Drug Manufacturers - General)

GRFS FAQ

What is GRFS's P/E ratio?

GRIFOLS SA ADR (GRFS) currently trades at a P/E ratio of 12.48.

What is GRFS's ROE?

GRIFOLS SA ADR reports a Return on Equity (ROE) of 7.61%.

What is GRFS's dividend yield?

GRIFOLS SA ADR offers a dividend yield of 2.32%.

What is GRFS's Deepscope Quality Score?

Deepscope rates GRFS's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GRFS?

Deepscope's AI Timing Score for GRFS is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GRFS belong to?

GRIFOLS SA ADR is classified under the Healthcare >> Drug Manufacturers - General sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2026-03-31)

GRFS

GRIFOLS SA ADR
USD 7.64
0.06 (0.79%) Day Change
12.48
P/E
0.11
D/E
7.6%
ROE
2.1%
ROA
2.32%
Div Yield
0.11
PEG
USD 7.64
Price
0.06 (0.79%)
Day Change
NEWS SCORE: 84

GRFS Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...

62

QUALITY

Signal
NEUTRAL
Signal Description
Company financial health is OK
Reason
Tỷ lệ ROE tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng 57%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 84
  Magic Formula Rank by ROA
1759
  Magic Formula Rank by ROE
1759
  Magic Formula Rank by ROIC
1333
  Price 7.64
  PBV / Sector
0.66 / 2.84
GREAT
  Earning Per Share 0.61
  PE / Sector
12.48 / 24.53
GOOD
  PEG or PE/Growth / Sector
0.11 / 0.08
GREAT
  Average 1M Daily Value
4.77 M
GREAT
  Average 1W Daily Value
4.27 M
GREAT
Yếu tố Kỹ thuật 14%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 43%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 62%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
5.58 / 18.17
  NPM Average (%) / Sector
3.36 / 17.77
  NPM Change Average (%) / Sector
77.49 / 93.90
GREAT
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
2.07 / 8.90
  ROA Average (%) / Sector
1.17 / 8.60
  ROA Change Average (%) / Sector
89.81 / 95.12
GREAT
  ROE (%) / Sector
7.61 / 27.16
  ROE Average (%) / Sector
4.33 / 13.13
  ROE Change Average (%) / Sector
85.24 / 97.95
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 41%
X
  Dividend (%) / Sector
2.32 / 2.55
  Dividend Average (%) / Sector
2.09 / 3.42
  Dividend Change Average (%) / Sector
25.39 / 1.75
GREAT
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:08:45
  Symbol GRFS
  Name GRIFOLS SA ADR
  Sector Healthcare >> Drug Manufacturers - General
  Market NASDAQ
  Listed Shares 680.58 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 5,185.98 / 241,254.65
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: Parque Empresarial Can Sant Joan, Barcelona, Spain, 08174

Phone: 34 935 71 22 00

Website: https://www.grifols.com

Employees: 25,000

Sector: Healthcare >> Drug Manufacturers - General

Description: Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

ME vs SECTOR Healthcare >> Drug Manufacturers - General

GRFS (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
GRFS
GRFS
USD 7.64 (0.79%)
+ Watch + Port Chart